Medigus to Increase its Share in AI Systems to 36%
September 12 2023 - 8:05AM
Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in
advanced medical solutions, innovative internet technologies and
electric vehicle and charging solutions, announced today that on
September 5, 2023, AI Systems Ltd. (“AI Systems”) approved the
conversion of a $1,240 thousand (4.75 million NIS)
convertible loan of the Company into shares of AI Systems.
Following the conversion, Medigus will hold a 36% stake in AI
Systems and become its largest shareholder.
AI Systems, a technology company traded on the
Tel Aviv Stock Exchange (TASE), is in negotiations to merge new
activity and further expand its technological endeavors.
This conversion of the convertible loan to
shares solidifies Medigus’ commitment to diversify its investments
with AI - based technologies and nurture its relationships with
cutting-edge technology companies.
About Medigus
Based in Israel, Medigus Ltd. (Nasdaq: MDGS) is
a technology company focused on innovative growth partnerships,
mainly in advanced medical solutions, digital commerce and electric
vehicle markets. Medigus’ affiliations in the medical solutions
arena include ownership in Polyrizon Ltd.. The Company’s affiliates
in digital commerce include Gix Internet Ltd., Jeffs’ Brands Ltd.
and Eventer Technologies Ltd. In the electric vehicle market,
Charging Robotics Ltd. and Revoltz Ltd. by way of Fuel Doctor
Holdings, Inc., are also part of the Company’s portfolio of
technology solution providers. Medigus is traded on the Nasdaq
Capital Market. To learn more about Medigus’ advanced technologies,
please visit http://www.medigus.com/.
Cautionary Note Regarding Forward
Looking Statements
This press release contains forward-looking
statements within the meaning of the “safe harbor” provisions of
the Private Securities Litigation Reform Act of 1995 and other
Federal securities laws. Words such as “expects,” “anticipates,”
“intends,” “plans,” “believes,” “seeks,” “estimates” and similar
expressions or variations of such words are intended to identify
forward-looking statements. Because such statements deal with
future events and are based on Medigus’ current expectations, they
are subject to various risks and uncertainties, and actual results,
performance or achievements of Medigus could differ materially from
those described in or implied by the statements in this press
release.
The forward-looking statements contained or
implied in this press release are subject to other risks and
uncertainties, including those discussed in any filings with the
SEC. Except as otherwise required by law, Medigus undertakes no
obligation to publicly release any revisions to these
forward-looking statements to reflect events or circumstances after
the date hereof or to reflect the occurrence of unanticipated
events. References and links to websites have been provided as a
convenience, and the information contained on such websites is not
incorporated by reference into this press release. Medigus is not
responsible for the contents of third-party websites.th
Company Contact: Tali Dinar Chief Financial
Officer +972-8-6466-880 ir@medigus.com
Medigus (NASDAQ:MDGS)
Historical Stock Chart
From Apr 2024 to May 2024
Medigus (NASDAQ:MDGS)
Historical Stock Chart
From May 2023 to May 2024